This review examines data from human and animal studies of the altered huntingtin protein associated with Huntington disease to assess the risk-benefit profile of huntingtin-lowering therapies for the treatment of people with Huntington disease.
from journals https://ift.tt/39dLix0
from journals https://ift.tt/39dLix0
Comments
Post a Comment